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First published June 29, 2005; doi:10.1152/ajpcell.00036.2005.—Dietary
polyunsaturated fatty acids (PUFAs) have been reported to exhibit
antiarrhythmic properties, which have been attributed to their avail-
ability to modulate Na, Ca2, and several K channels. However,
their effects on human ether-a-go-go-related gene (HERG) channels
are unknown. In this study we have analyzed the effects of arachi-
donic acid (AA, -6) and docosahexaenoic acid (DHA, -3) on
HERG channels stably expressed in Chinese hamster ovary cells by
using the whole cell patch-clamp technique. At 10 M, AA and DHA
blocked HERG channels, at the end of 5-s pulses to 10 mV, to a
similar extent (37.7  2.4% vs. 50.2  8.1%, n  7–10, P  0.05).
5,6,11,14-Eicosatetrayenoic acid, a nonmetabolizable AA analog,
induced effects similar to those of AA on HERG current. Both PUFAs
shifted the midpoint of activation curves of HERG channels by
5.1  1.8 mV (n  10, P  0.05) and 11.2  1.1 mV (n  7, P 
0.01). Also, AA and DHA shifted the midpoint of inactivation curves
by 12.0  3.9 mV (n  4; P  0.05) and 15.8  4.3 mV (n 
4; P  0.05), respectively. DHA and AA accelerated the deactivation
kinetics and slowed the inactivation kinetics at potentials positive to
40 mV. Block induced by DHA, but not that produced by AA, was
higher when measured after applying a pulse to 120 mV (I3O).
Finally, both AA and DHA induced a use-dependent inhibition of
HERG channels. In summary, block induced by AA and DHA was
time, voltage, and use dependent. The results obtained suggest that
both PUFAs bind preferentially to the open state of the channel,
although an interaction with inactivated HERG channels cannot be
ruled out for AA.
K channel; membrane currents; ion channels; arrhythmia; antiar-
rhythmics
POLYUNSATURATED FATTY ACIDS (PUFAs) present in nature be-
long to two main classes: -6 class, mostly present in vegeta-
ble oils; and -3 class, which comes mostly from fish. Both are
“essential” because they are necessary for an optimal health
status and cannot be synthesized de novo. In addition, mam-
mals cannot convert -6 into -3 PUFAs. The dramatic in-
crease in the -6/-3 ratio in the diet of the population of
Western countries after the industrial revolution has contrib-
uted to the rise in cardiovascular disease (7, 21). There is a
growing body of evidence that dietary -3 PUFAs, especially
docosahexaenoic acid (DHA), play an important role in the
prevention of coronary heart disease, in decreasing the risk of
sudden cardiac death, and, in particular, in preventing fatal
ventricular arrhythmias (1, 5, 8, 10, 21, 37). The cardioprotec-
tive effects of -3 PUFAs have been attributed to their avail-
ability to modulate several ionic channels involved in the onset
and maintenance of the cardiac action potential (21, 22).
PUFAs block Na channels by binding to the receptor site that
share local anesthetics and antiarrhythmic drugs (29, 32, 42).
PUFAs also interact with other cardiac ion channels, inhibiting
ultrarapid delayed-rectifier K current (IK,ur), transient out-
ward current (Ito), and Ca2 current (ICa) (14, 15, 22, 40) and
enhancing long-activated delayed-rectifier K current (IK1)
and slow-activated delayed-rectifier K current (IKs; the latter
by their interaction with minK) (9, 24). Moreover, it has been
demonstrated that membrane lipids can convert Kv A-type
channels into delayed rectifiers and vice versa. Thus phospho-
inositides remove N-type inactivation, whereas arachidonic
acid (AA) converts Kv-delayed rectifiers into A-type rectifier
channels (30). However, the effects of PUFAs on human
ether-a-go-go-related gene (HERG) channels have not been
studied yet. HERG channel activity determines the ventricular
action potential duration and, therefore, the refractory period.
Mutations in the gene encoding HERG channels are involved
in the genotype of congenital long QT syndrome (36). More-
over, most drugs that induce acquired long QT syndrome block
HERG channels (35), and thus, HERG channels can be con-
sidered a target of antiarrhythmic agents. The purpose of the
present study is to analyze and compare the effects of -6 and
-3 PUFAs (AA, precursor of the prostaglandins, leukotrienes,
and thromboxane cascade; and DHA) on HERG channels,
whose activity determines the action potential duration (23). A
preliminary report of this study has been published in abstract
form (12).
METHODS AND MATERIALS
Cell culture. Stably transfected Chinese hamster ovary cells with
the gene encoding HERG channels (a gift of Drs. S. Nattel, T. E.
He´bert, and W. Weerapura) were cultured at 37°C in Ham’s F-12
medium supplemented with geneticine (600 g/ml), penicillin-strep-
tomycin (800 IU and 200 g/ml, respectively), and 10% bovine
serum, in a 5% CO2 atmosphere (2, 11). Cultures were passaged every
3–5 days with the use of a brief trypsin treatment. Before experimental
use, the cells were removed from the dish with a rubber policeman, a
procedure that left the majority of the cells intact. The cell suspension
was stored at room temperature (21–23°C) and used within 12 h for all
the experiments reported.
Electrophysiological recording. The intracellular pipette-filling so-
lution contained (in mM) 80 K-aspartate, 50 KCl, 3 phosphocreatine,
10 KH2PO4, 3 MgATP, 10 HEPES-K, and 5 EGTA and was adjusted
to pH 7.25 with KOH. The bath solution contained (in mM) 130 NaCl,
4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES-Na, and 10 glucose, and was
adjusted to pH 7.4 with NaOH. AA, DHA, and 5,8,11,14-eicosatet-
raynoic acid (ETYA) (Sigma, St. Louis, MO) were dissolved in
ethanol at concentrations of 56.5, 52.5, and 10 mM, respectively.
Experiments were performed to test the potential effects of ethanol
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(30 l/100 ml) on HERG channels. Ethanol, at this concentration, did
not modify the outward maximum current (56.3  10.3 vs. 52.7 
11.2 pA; n  7, P  0.05) nor the maximum peak tail current (68.7 
16.4 to 63.6  16.7 pA; n  7, P  0.05). AA and DHA were stored
under argon atmosphere and maintained in sealed ampoules protected
from light at 40°C to prevent oxidation. HERG currents were
recorded at room temperature (21–23°C) using the whole cell patch-
clamp technique (13) with an Axopatch 200A patch-clamp amplifier
(Axon Instruments, Foster City, CA). Micropipettes were pulled from
borosilicate glass capillary tubes (GD-1; Narishige, Tokyo, Japan) on
a programmable horizontal puller (Sutter Instrument, San Rafael, CA)
and heat polished with a microforge (Narishige). Micropipette resis-
tance was 1–3 M	. Maximum HERG tail-current amplitudes aver-
aged 717  123 pA, mean uncompensated access resistance was
1.5  0.5 M	, and cell capacitance 29.8  2.0 pF (n  11). Thus no
significant voltage errors (5 mV) were expected. HERG currents
were filtered at 100 Hz and sampled at 200 Hz. Cells were held at80
mV. After control data were obtained, bath perfusion was switched to
fatty acid-containing solution. The effects of drug infusion were
monitored with test pulses to 10 mV applied every 30 s until steady
state was obtained. Steady-state current-voltage relationships (I-V)
were obtained by averaging the current over a small window (2–5 ms)
at the end of 5-s depolarizing pulses. Between 80 and 50 mV only
passive linear leak was observed and least squares fit to these data
were used for passive leak correction. Deactivating tail currents were
recorded at 60 mV. The activation curves were obtained from the
tail current amplitude measured at the maximum peak value. The
inactivation curves were obtained from the maximum current ampli-
tude measured at a test pulse at 30 mV applied after a two-pulse
protocol that consisted of a 1-s depolarizing pulse from 80 mV to
30 mV followed by a second pulse of 20 ms in duration to different
membrane potentials between 120 mV and 10 mV. Other pulse
protocols are described in RESULTS. Command potentials and data
acquisition were generated by using the CLAMPEX program of
pCLAMP 6.0.1, 9.0.1 (Axon Instruments). Data analysis was per-
formed using the CLAMPfit program of pCLAMP 9.0.1, Origin 7.0.3
(Microcal Software, Northampton, MA), and other custom-made
analysis programs. Deactivation was fitted to a biexponential process
y  C  A1exp
 t/1 A2exp
 t/2 (1)
where 1 and 2 are the system time constants, A1 and A2 are the
amplitudes of each component of the exponential, and C is the
baseline value. Half-maximal voltages (Eh) and slope factors (s) of
activation and inactivation were determined by fitting data with a
Boltzmann equation y  1/{1  exp[(E  Eh)/s]}. The curve-fitting
procedure used a nonlinear least-squares (Gauss-Newton) algorithm;
results were displayed in linear and semilogarithmic format, to-
gether with the difference plot. Goodness of fit was judged by the 2
criterion and by inspection for systematic nonrandom trends in the
difference plot.
Statistical methods. Results are expressed as means  SE. Direct
comparisons between mean values in control conditions and in the
presence of drug for a single variable were performed by paired
Student’s t-test. Differences were considered significant if P  0.05.
Comparisons between the three groups were performed by a one-way
ANOVA, with a posterior Newman-Keuls test if P  0.05.
RESULTS
Free fatty acids are generally toxic to cells and are kept at
low micromolar concentrations in plasma. These levels can
vary greatly depending on the hormonal, metabolic, and nutri-
tional state of the individual. Around 99.9% of free fatty acids
are carried in plasma bound to albumin. The low plasma free
fatty acid concentrations are maintained by the competition
between the affinity of the albumin-binding sites and cell
membrane phospholipids for free fatty acids. The range of free
AA and DHA in human plasma is 5.3–13.1 M and 2.8 M,
respectively (6). The choice of the concentration of DHA (10
M) is based on the reported EC50 for the effects of PUFAs on
ion channels that ranges between 1 and 30 M (14, 43). This
concentration was also used to show antiarrhythmic properties
of this fatty acid in single cell (16–18). Following the same
reasoning and for better comparisons between -3 and -6
PUFAs effects on HERG channels, the same AA concentration
was used.
Voltage-dependent block of HERG channels induced by AA
and DHA. Figure 1A shows HERG currents obtained after
applying 5-s pulses from a holding potential of 80 to 50
mV in 10-mV steps in the absence and in the presence of 10
M AA or DHA. Deactivating tail currents were measured at
60 mV. Figure 1B shows the I-V relationships obtained by
plotting the amplitude of the HERG current measured at the
end of the 5-s pulses vs. membrane potential in the absence and
in the presence of AA (Fig. 1B, left) or DHA (Fig. 1B, right).
Under control conditions, the I-V exhibits the characteristic
bell shape that increases from 50 mV to 10 mV (12.4 
1.8 mV, n  19) and, due to the fast C-type inactivation of
HERG channels, it decreased with further depolarizations (38,
39). Thus steady-state drug-induced block was measured at the
end of 5-s pulses to 10 mV. Blockade induced by AA
(37.7  2.4%, n  10) was similar to that produced by DHA
(50.2  8.1%, n  7; P  0.05). However, block induced by
DHA was higher than that produced by AA measured at the
maximum peak of the tail current recorded at 60 mV after
applying a 5-s depolarizing test pulse to 0 mV (47.4  4.2%,
n  10, vs. 58.3  2.7%, n  7, in the presence of AA and
DHA, respectively; P  0.05). AA and DHA shifted the
midpoint of activation curves without modifying the slope
factors, being the voltage shift induced by DHA higher than
that produced by AA (11.2  1.1 mV, n  7 vs. 5.1  1.8
mV, n  10; P  0.05) (Fig. 1C). These results, 1) the higher
degree of block observed in the tail currents, and 2) the
negative shift of the activation curve, suggest an open-channel
block mechanism.
To determine the fully activated I-V relationships (Fig. 1E),
a double pulse protocol was applied (Fig. 1D). A 1-s step to
30 mV to activate HERG channels and a test pulse to
potentials from 120 to 10 mV in 10-mV steps were
Fig. 1. Effects of arachidonic acid (AA) and docosahexanoic acid (DHA; 10 M) on human ether-a-go-go-related gene (HERG) currents. A: current records
obtained upon depolarization from a holding potential of 80 up to 50 mV in 10-mV steps and upon repolarization to 60 mV. Current records obtained in
the absence and in the presence of AA (left) and DHA (right). B: current-voltage (I-V) relationships (5-s isochronal) of HERG channels obtained in the absence
and in the presence of each fatty acid. C: activation curves of HERG channels obtained under control conditions and in the presence of AA or DHA. Dotted lines
reflect the normalized activation curves obtained in the presence of polyunsaturated fatty acids (PUFAs) and matching control values. Open stars represent the
relative current obtained at different membrane potentials. Each point represents the means  SE of 7–10 experiments. Eh, half-maximal voltages. *P  0.05
and **P  0.01 vs. control. D: records obtained during the application of the pulse protocol shown in the top of the figure in the absence and in the presence
of AA (left) or DHA (right). E: fully activated I-V relationships of HERG channels obtained in the absence and in the presence of AA or DHA.
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applied. The pulse to 30 mV was positive enough to induce
full conductance of HERG channels but also inactivated a large
number of channels (inward rectification from potentials pos-
itive to 40 mV). Block induced by 10 M AA and DHA was
not voltage-dependent and when measured at 120 mV aver-
aged 41.8  7.1% and 56.2  3.5% (n  4; P  0.05),
respectively.
AA metabolism occurs via three principal pathways: cyclo-
oxygenase, lipooxygenase, and epoxygenase catalysis. To test
whether the AA effects were due to its direct interaction with
HERG channels or to the actions of some of its metabolites, the
electrophysiological effects of its nonmetabolizable analog
ETYA were analyzed (Fig. 2). ETYA (10 M) inhibited
HERG current by 37.4  3.7% and 42.5  5.8%, measured at
the end of 5-s pulses to 10 mV and at the maximum peak tail
currents, respectively (n  7; P  0.05), similar to the
inhibition produced by AA at the same concentration. More-
over, as it can be observed in Fig. 2, B–D, the kinetics of block
induced by ETYA was similar to that observed in the presence
of AA. Therefore, these results suggest that the AA effects
observed on HERG channels are not due to AA metabolites.
Time-dependent block of HERG channels induced by AA and
DHA. AA and DHA accelerated the time course of the maxi-
mum outward current and decreased its amplitude (Fig. 3A).
The initial increase of the current is likely due to the negative
voltage shift of the activation curve induced by both PUFAs. In
this figure, the control traces exponentially rise during depo-
larization, whereas in the presence of both PUFAs, the current
remains constant after 1 s. Thus the relative current (IFatty-
Acid/IControl) vs. time of depolarization was plotted (Fig. 3A).
These ratio traces are a composite of the block, which seems to
reach a maximum within the first second, which could repre-
sent a mixture of tonic- and time-dependent block. The relative
current decreased in the presence of both PUFAs with a similar
time constant (  549.6  117.9 ms, n  8 vs. 731.6  109.6
ms, n  10, in the presence of AA and DHA, respectively, P 
0.05).
Time dependency of block was also apparent in the tail
currents, as shown in Fig. 3B, which shows superimposed tail
currents recorded under control conditions and in the presence
of AA or DHA. The time course of deactivation of HERG
channels was fitted to a biexponential function (fast and slow).
AA accelerated fast (from 377.7  30.8 ms to 243.8  45.6
ms, n  8; P  0.05) and slow (from 1923.7  257.9 ms to
1599.9  198.1 ms, n  8; P  0.05) of deactivation without
modifying the ratio of amplitudes [Afast/(Afast  Aslow)] (0.31
0.09 vs. 0.34  0.06, n  8, P  0.05). DHA accelerated fast
(from 351.6  41.2 to 222.3  24.9 ms, n  9; P  0.05)
without modifying slow (1713.7  264.0 vs. 1345.7  85.7
ms, n  9; P  0.05) or the ratio of amplitudes (0.51  0.05
vs. 0.48  0.04, n  9, P  0.05).
To analyze the effects of AA or DHA on the inactivation
kinetics, the three-pulse protocol shown in the top of Fig. 4 was
applied. Holding potential was maintained at 80 mV, and
after a 2-s step to 40 mV that fully activates HERG channels,
a 20-ms pulse to120 mV that promotes the recovery from the
fast inactivation of HERG channels was applied. Then, 20-ms
test pulses to membrane potentials between 0 and 50 mV
were applied. The degree of block induced by DHA when
measured at the maximum peak current recorded during the
application of the test pulse to 0 mV was higher than that
induced by AA. Neither DHA nor AA modified the time
constant of inactivation (Inac) at membrane potentials between
0 and 40 mV. However, at membrane potentials positive to
40 mV, AA and DHA increased the Inac, which can be
explained either by a fatty acid-induced stabilization of the
open state of HERG channels or a destabilization of the
inactivated state. Figure 4B shows the degree of block induced
by AA and DHA at the end of 5-s pulses to 0 mV (End 5-s) and
at the maximum peak current recorded during the application
Fig. 2. Effects of 5,6,11,14-eicosatetrayenoic acid
(ETYA; 10 M) on HERG currents. A: current
records obtained upon depolarization from a holding
potential of 80 mV up to 10 mV and upon
repolarization to 60 mV in the absence and in the
presence of ETYA. Inset, first 5 s of the current
traces shown in A. B: relative current (IETYA/IControl)
vs. time of depolarization. Current exponentially
decreased during depolarization. C: tail currents
recorded upon repolarization to 60 mV after a 5-s
pulse to 10 mV in the absence and in the presence
of ETYA. D: tail current traces shown in C normal-
ized to match control values.
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of the test pulse to 0 mV (Maximum). DHA induced a higher
block (P  0.05) when measured at the maximum peak current
than at the end of 5-s depolarizing pulses, thus suggesting an
open channel block. However, block of HERG channels in-
duced by AA was similar under both experimental conditions.
Effects of AA and DHA on HERG inactivation availability.
To analyze the effects of AA and DHA on the inactivation
availability, a three-pulse voltage clamp protocol was used
(Fig. 5) (38, 39). Figure 5A shows the effects of 10 M AA and
DHA on the voltage dependence of HERG channels (“inacti-
vation availability”). The dynamic nature of HERG currents
precludes direct measurements of “steady-state” inactivation,
but the data shown approximate a voltage dependence of the
distribution of channels between open and inactivated states.
The 1-s step to 30 mV fully activates and inactivates the
channels. The second step to the test potential (between 120
and 10 mV) allows some fraction of the channels to recover
from inactivation. The instantaneous current after the third step
to 30 mV allows measurements of the fraction of channels
that have recovered from inactivation during the preceding test
step. Figure 5B shows a plot of the current measured at 30
mV as a function of voltage. HERG current falls off at negative
potentials because the channels also begin to deactivate during
the 20-ms pulse. We corrected the current magnitude for the
amount of deactivation at each voltage by fitting the deactivat-
ing tail currents with an exponential function and then back-
extrapolated this fit to the beginning of the hyperpolarizing
pulse, which permitted us to estimate the fraction of channels
deactivating during the 20-ms pulse and then increase the
outward current accordingly (38). Figure 5C shows the Boltz-
mann fit of the corrected data in the absence and in the
presence of the two PUFAs. AA and DHA shifted the apparent
voltage dependence of channel availability toward more posi-
tive potentials by 12.0  3.9 mV (n  4, P  0.05) and
15.8  4.3 mV (n  4, P  0.05), respectively, without
modifying the slope factor.
State- and use-dependent effects of AA and DHA on HERG
channels. To further analyze the interaction between AA or
DHA and HERG channels, we applied the voltage protocol
shown in the top of Fig. 6. From a holding potential of 80
mV, HERG channels were rapidly activated by a 5-ms step to
180 mV, followed by a 200-ms step to 0 mV, before
returning to 60 mV. With this protocol, HERG current
amplitude at 0 mV, under control conditions, was nearly
constant. In the presence of AA or DHA, the amplitude of
HERG current exponentially declined to a steady-state level as
additional block developed during the step to 0 mV. The time
course of AA- and DHA-induced HERG current decay was
determined by dividing the current trace obtained in the pres-
ence of the fatty acid and the control trace. This current was
fitted as a monoexponential decay to calculate the time con-
stant of block of the open state of HERG channels (B) (27.9 
5.6 ms, n  3, and 39.2  5.7 ms, n  5, for AA and DHA).
This pulse protocol also allowed us to measure the recovery
kinetics by fitting the hook of the tail current at 60 mV (Fig.
6A). AA or DHA, at 10 M, did not modify the recovery
process (6.4  1.3 vs. 6.5  1.0 ms; n  4, P  0.05 in the
absence and in the presence of AA and 5.9  0.6 vs. 4.9  0.5
ms; n  5, P  0.05 in the absence and in the presence of
DHA). This voltage pulse protocol was applied at 1.0 Hz and,
as can be observed, AA and DHA decreased in a use-depen-
dent manner the amplitude of HERG current. This pattern is
consistent with a preferential block of the open state of the
channel. In the presence of DHA, the maximum peak current
was higher than under control conditions, which can be due to
the slower Inac at positive potentials (180 mV).
AA and DHA HERG current inhibition during cardiac ac-
tion potential. Because of the complex gating of HERG, it is
difficult to predict the effects of AA and DHA on ionic currents
during a cardiac action potential (AP), where the membrane
voltage is continually changing with time. To assess this issue,
the effects of AA and DHA were analyzed using the AP clamp
technique as shown in Fig. 7. The frequency of stimulation
used was 1 Hz. Under control conditions, HERG current
rapidly inactivates during the upstroke. As the action potential
repolarizes, HERG channels rapidly recover from inactivation
to reopen and slowly deactivate, increasing their occupancy in
the open state. The current deactivates with the final phase of
Fig. 3. Time-dependent block induced by AA and DHA (10 M). A, top:
current traces obtained after depolarizing the cell membrane from 80 to 10
mV in the absence and in the presence of AA or DHA. Bottom, plot of the
relative current (IFattyAcid/IControl) vs. time of depolarization. Current exponen-
tially decreased during depolarization. B, top: tail currents recorded upon
repolarization to 60 mV after a 5-s pulse to 0 mV in the absence and in the
presence of AA or DHA. Bottom, tail current traces normalized to match
control values.
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repolarization. AA (10 M) decreased the maximum peak
current by 43.3 1.6% (n 3). DHA increased HERG current
during the upstroke and decreased it at the end of the AP to an
extent similar to that of AA (48.1  8.3%, n  3, P  0.05).
DISCUSSION
In the present study, the effects of AA and DHA on HERG
channels have been studied. We found that, at relevant plasma
concentrations, both PUFAs block HERG channels to a similar
extent. Moreover, the effects of AA on HERG channels appear
to be due to this PUFA and not to its metabolites because its
actions are mimicked by the nonmetabolizable analog ETYA.
Effects of AA and DHA on HERG channels. AA and DHA
block HERG channels in a voltage-, time-, and state-dependent
manner, which is consistent with an open channel block mech-
anism. In fact, block induced by both PUFAs steeply increased
in the range of membrane potentials that coincides with the
range of HERG channel activation, suggesting that their bind-
ing may derive a significant fraction of its voltage sensitivity
through coupling to channel gating. Unfortunately, at depolar-
ized voltages the open and inactivated conformations of HERG
channels are in rapid equilibrium, making it difficult to un-
equivocally identify the state(s) with which these two PUFAs
interact.
Whereas AA induced a similar inhibition of the HERG
current when measured at the end of depolarizing pulses to
10 mV and at the maximum tail currents, DHA inhibited this
current to a higher extent when measured at the maximum tail
current than at the end of depolarizing steps to 10 mV.
During depolarization, HERG channels inactivate faster than
they activate and thus the amplitude of the current is reduced.
On repolarization, closed channels transit through the open
state, resulting in tail currents with higher amplitude (38, 39).
In agreement with these results, block induced by AA when
measured at the maximum peak current of a test pulse to 0 mV
applied after a hyperpolarizing pulse to 120 mV (that pro-
motes the I3O transition) was similar to that observed at the
same voltage at the end of a 5-s depolarizing pulse. However,
DHA-induced block, when measured at the maximum peak
current of a test pulse to 0 mV applied after a hyperpolarizing
pulse to 120 mV, was higher than that observed at the same
voltage at the end of a 5-s depolarizing pulse. Block induced by
AA and DHA was also time dependent, being evident after a
prepulse to 180 mV, suggesting a rapid drug binding to
activated HERG channels, as previously described for cocaine
and bupivacaine-type local anesthetics (11, 44). This time
dependency was also evident in the deactivation process of
HERG channels that was accelerated in the presence of both
AA and DHA. However, AA and DHA did not modify the
onset kinetics of the inactivation process or the recovery
process. The faster deactivation induced by both PUFAs,
together with their lack of effect on the recovery kinetics,
suggests that a very fast dissociation rate constant from HERG
channels is consistent with an open channel block mechanism,
as has been proposed for propafenone (2). Another piece of
evidence of an open channel interaction between both PUFAs
and HERG channels is the use-dependent inhibition of the
current. Taken together, all these results suggest that both AA
Fig. 4. Effects of 10 M AA or DHA on HERG
inactivation kinetics. A, top: current records of
test pulses obtained in the absence and in the
presence of each fatty acid. Bottom, plots of the
time constant of inactivation at different mem-
brane potentials in the absence and in the pres-
ence of each agent. B: graph showing the degree
of block induced by AA or DHA measured at
the end of 5-s pulses to 0 mV (End 5-s) or at the
maximum peak current recorded at a test pulse
to 0 mV after a test pulse to 40 mV during 2-s
and followed by a 20-ms pulse to 120 mV
(Maximum) indicated by an arrow in the pulse
protocol. Each point represents the means  SE
of 7–9 experiments. *P  0.05 vs. control con-
ditions.
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and DHA preferentially bind to the open state of HERG
channels, and that DHA exhibits a higher affinity for this state
of the channel.
We also observed that AA and DHA produced a positive
shift in the inactivation curve. This could be explained either
by 1) stabilization of the open state of HERG channels or 2)
destabilizing the inactivation process; i.e., without modifying
the onset but accelerating the offset of inactivation. In both
cases, the shift of the inactivation curve would be the result of
the interaction between PUFAs and a closed state of HERG
channels (tonic block). This tonic block is likely to influence
the apparent steady-state inactivation and perhaps the activa-
tion process because both PUFAs accelerate the deactivation
process. All of these results suggest that AA and DHA pref-
erentially block the open state of HERG channels, but also that
they interact with a closed state, thus producing changes in
channel gating. Finally, the similar degree of AA-induced
inhibition of the current at the end of 5-s depolarizing pulses
(when most channels are inactivated) and at the maximum tail
current or at the maximum peak current after applying a 120
mV step cannot permit us to rule out an interaction between
AA and the inactivated state of HERG channels. Moreover, it
has been shown that AA regulates the inactivation process in
other K channels in such a way that introduces rapid voltage
dependent inactivation into noninactivating Kv channels (30).
The authors explain these results under the framework that
AA closes Kv channels by inducing conformational alter-
ations in the selectivity filter region (30) and propose that
Kv channel inactivation is lipid dependent and that this
process has a high affinity, comparable to that of KATP
channels for phosphoinositides (3). Oliver et al. (30) pro-
pose that AA inserts into the cell membrane from either
side, interacts with the channel protein, and, allosterically,
induces a fast closure of the open Kv channel pore through
Fig. 5. Apparent voltage dependence of channel availability. The pulse protocol used to obtain each data point is shown at top. A: original traces obtained after
applying such pulse protocol in the absence and in the presence of 10 M AA and DHA. B: peak current observed immediately after stepping to 30 mV was
then plotted vs. test potential in the absence and in the presence of 10 M of AA (left) and DHA (right). Currents decreased at negative potentials due to
deactivation during the 20-ms pulse. C: corrected data for deactivation (see RESULTS) together with the Boltzmann fit. Each point represents the mean  SE of
4 experiments. The dashed lines represent the normalized fits to matching control. *P  0.05.
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conformational modifications in the selectivity filter. Fur-
ther studies are required to discern the possible role of AA
on the inactivation of HERG channels.
Clinical implications of this study. Many studies suggest that
-3 fatty acids have beneficial effects on human health. In
contrast, a diet enriched in -6 fatty acids provokes athero-
sclerosis, carcinogenesis, and heart disease (20). In the present
study we have demonstrated that AA and DHA block HERG
channels. The plasma levels of these two PUFAs vary greatly
depending on the hormonal, metabolic, and nutritional state of
the individual. Around 99.9% of fatty acids are carried in
plasma bound to albumin and the range of free AA and DHA
in human plasma is 5.3–13.1 M and 2.8 M, respectively
(6). The EC50 values calculated from the blockade produced by
both PUFAs at 10 M are well within their physiological
plasma range. Therefore, we can conclude that both PUFAs
block HERG channels at concentrations within their physio-
logical plasma levels.
It has been described that AA is able to modulate several ion
currents (28). In fact, AA decreases L-type ICa (ICa,L), T-type
ICa (ICa,T), Ito, INa, and Kv1.5 currents (4, 14, 40, 41) and
activates IK1 (25). AA plasma levels are known to be increased
during ischemia and reperfusion at the intracellular and extra-
cellular levels (19), which, in the light of previous and present
Fig. 6. Time-dependent block of AA and DHA (10 M) after a fast activation of HERG channels, using the pulse protocol shown at the top. A: first record
obtained in the absence and in the presence of AA or DHA. B: relative current (IFattyAcid/IControl) during the step to 0 mV together with its monoexponential fit.
C: use-dependent block of HERG channels induced by AA and DHA obtained after applying the pulse protocol shown at top at 1.0 Hz. Inset, records obtained
in the absence and in the presence of AA or DHA.
Fig. 7. Effect of 10 M AA (A) and DHA (B)
on HERG currents evoked by an action potential
waveform from a guinea pig ventricular myo-
cyte. The frequency of stimulation was 1 Hz.
Arrow indicates 0 current level.
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results, could represent a “natural” protective mechanism to
prevent arrhythmias under these pathological conditions. On
the other hand, it has been shown that DHA exhibits potential
cardioprotective effects that have been associated with their
antiarrhythmic effects (21). DHA’s antiarrhythmic effects have
been attributed to its actions on the cardiac ion channels
responsible for the onset and maintaining of the cardiac action
potential, mostly on its inhibitory effects on Na and ICa,L
channels (22, 42), because DHA has inhibitory effects on INa,
but not on ICa,L, that are higher than those of AA (41). DHA
inhibitory effects on INa and ICa theoretically should shorten
the cardiac action potential duration. Moreover, DHA enhances
IKs, which would further shorten the cardiac action potential
duration (9). However, experiments performed in rat ventric-
ular myocytes demonstrate that DHA slightly prolongs the rat
cardiac action potential (4, 26). In the present study we have
demonstrated that DHA blocks HERG channels. Most drugs
that selectively block HERG channels prolong the cardiac
action potential (34). However, interactions of nonselective
HERG channel blockers with other cardiac ion channels may
mitigate or exacerbate the prolongation of action potential
duration (27, 31, 33). Because DHA inhibits INa and ICa and
enhances IKs (effects that would shorten the cardiac action
potential), but also inhibits Ito, IK,ur, and HERG (which should
produce a lengthening of the action potential duration), the
result should be a modest effect on the time of repolarization.
Besides these effects on the action potential duration, it should
be stated that its inhibitory effects on Na, Ca2, and several
K channels (Kv4 and HERG channels) would result in a
lengthening of the refractory period and a decrease of cardiac
excitability, thus contributing to its antiarrhythmic effects.
To our knowledge, this is the first demonstration that HERG
channels are modulated by AA and DHA. The -3 antiarrhyth-
mic effects have been attributed to their availability to modu-
late cardiac ion channels involved in the genesis and mainte-
nance of the cardiac action potential (21). Our results suggest
that AA and DHA block HERG channels mainly by binding to
the open state of the channel. These PUFAs’ actions on HERG
channels have to be taken into account to explain the antiar-
rhythmic effects of AA during ischemia and those previously
reported for DHA in subjects consuming a diet rich in fish and
fish oils.
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